Cancer cells have many strategies for resisting therapy. One such strategy is survivin, a protein that drives the division of diseased cells and prevents them from dying.
Nanobody-based strategy targets survivin to weaken cancer cells
- Post author:admin
- Post published:September 10, 2025
- Post category:uncategorized